ShEEP Request for Nanostring nCounter Spring Profiler
ShEEP Request for Nanostring nCounter Spring Profiler
批准号:
9213421
负责人:
Robert Keith
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-05-01 至 2016-09-30
关键词:
AgonistAlzheimer&aposs DiseaseAwardBioinformaticsBloodBrainCREB1 geneCellsComplementary DNAComputer softwareDNA SequenceDataData AnalysesDetectionDiseaseDoctor of PhilosophyFGFR1 geneFormalinGene ChipsGenetic TranscriptionGenomicsHandHead and Neck CancerK-Series Research Career ProgramsKynurenineLengthLibrariesMalignant NeoplasmsMalignant neoplasm of lungMarketingMethodsMolecular ProfilingNeoplasm MetastasisOncogenesOrganismPPAR gammaParaffin EmbeddingPathway interactionsPreparationPrincipal InvestigatorProcessProductivityRNARNA SequencesReactionRequest for ApplicationsResearchResearch InstituteResearch PersonnelResearch Project GrantsRoleSamplingSpecialistSystemTechnologyTimeToxoplasmaTrainingTubeTuberculosisVariantVeteransabstractingcancer chemopreventioncostdesignfaculty researchgenome-wideindividual patientinstrumentinterestnano-stringpersonalized medicineresponse biomarkersuicidal behaviortissue fixingtooltumor progressionuser-friendlywastingweb site
中文摘要
摘要
在此应用中,我们请求购买Nanostring nCounter Sprint Profiler仪器。的
nCounter Sprint Profiler是一款用户友好、占用空间小、中等通量的仪器,旨在检测
并在单个样品中定量多达800种不同的RNA或DNA序列。这项技术允许表达
在单个细胞或整个生物体中进行分析,并且被设计为在单个qPCR之间弥合差距。
反应和全球技术,如表达阵列或全基因组测序。这项技术
代表了基因组研究的一个重大进展,通过允许检测和定量数百个
以比传统方法低得多的成本和时间靶序列。以下研究项目将
由升级系统支持:
1)Robert基思,医学博士,主要研究者:BLR&D优异评审奖“肺用PPAR γ激动剂
癌症化学预防”
2)霍华德李,医学博士,首席研究员:BLR&D职业发展奖“PPARgamma的作用
肺癌的进展和转移”
3)Nicholas Walter,MD,首席研究员:CSR&D职业发展奖“血液表达
概况作为结核病反应的生物标志物”
4)Subbiah Pugazhenthi,博士,主要研究者:BLR&D Merit Review Award“CREB的机制
阿尔茨海默病大脑的失调”
5)林恩希斯利,博士,主要研究者:BLR&D优秀评论奖“FGFR 1致癌基因驱动因子
头颈癌的发病机制”
6)丽莎布伦纳,博士,共同首席研究员:CSR&D优秀评论奖“弓形虫,
犬尿氨酸途径和退伍军人的自杀行为”
7)Edward Chan,医学博士,Merit Review和丹佛研究所首席研究员
英文摘要
Abstract
In this application we request the purchase of a Nanostring nCounter Sprint Profiler instrument. The
nCounter Sprint Profiler is a user friendly, small-footprint, medium throughput instrument designed to detect
and quantify up to 800 different RNA or DNA sequences in a single sample. This technology allows expression
analysis in a single cell or an entire organism and is designed to bridge the gap between single qPCR
reactions and global technologies like expression arrays or genome wide sequencing. This technology
represents a major advance in genomic research, by allowing detection and quantification of hundreds of
target sequences at much lower cost and time than traditional methods. The following research projects will be
supported by the upgrades system:
1) Robert Keith, MD, Principal Investigator: BLR&D Merit Review Award “PPAR gamma Agonists for Lung
Cancer Chemoprevention”
2) Howard Li, MD, Principal Investigator: BLR&D Career Development Award “The Role of PPARgamma
in Lung Cancer Progression and Metastasis”
3) Nicholas Walter, MD, Principal Investigator: CSR&D Career Development Award “Blood Expression
Profiles as a Biomarker for Responses to Tuberculosis”
4) Subbiah Pugazhenthi, PhD, Principal Investigator: BLR&D Merit Review Award “Mechanism of CREB
dysregulation in Alzheimer brain”
5) Lynn Heasley, PhD, Principal Investigator: BLR&D Merit Review Award “An FGFR1 oncogene driver
pathway in head and neck cancer”
6) Lisa Brenner, PhD, Co-Principal Investigator: CSR&D Merit Review Award “Toxoplasma gondi, the
kynurenine pathway, and suicidal behavior in veterans”
7) Edward Chan, MD, Principal Investigator, Merit Review and Denver Research Institute
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PPAR gamma Agonists for Lung Cancer Chemoprevention
-
批准号:8242628
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:Robert Keith
-
依托单位:
PPAR gamma Agonists for Lung Cancer Chemoprevention
-
批准号:8047773
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:Robert Keith
-
依托单位:
PPAR gamma Agonists for Lung Cancer Chemoprevention
-
批准号:8394610
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:Robert Keith
-
依托单位:
PPAR gamma Agonists for Lung Cancer Chemoprevention
-
批准号:8922356
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Robert Keith
-
依托单位:
PPAR gamma Agonists for Lung Cancer Chemoprevention
-
批准号:9206065
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Robert Keith
-
依托单位:
PPAR gamma Agonists for Lung Cancer Chemoprevention
-
批准号:10058201
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Robert Keith
-
依托单位:
Clinical Trials Core
-
批准号:8664641
-
项目类别:
-
资助金额:$26.18万
-
财政年份:--
-
负责人:Robert Keith
-
依托单位:
Clinical Trials Core
-
批准号:9369733
-
项目类别:
-
资助金额:$28.37万
-
财政年份:--
-
负责人:Robert Keith
-
依托单位: